Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 76.50
0.00 (0.00%)
Nov 10, 2026, 1:24 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 5.11 billion as of November 9, 2026. It is the 22,134th most valuable company in the world and the 1,042nd biggest in Taiwan. Its market cap has decreased by 72.78% in one year.
Market Cap
5.11B
Enterprise Value
2.83B
Revenue
3.00M
Global Rank
Country Rank
#1,042 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 5.11B, an increase of 99.23%. That is a compound annual growth rate of 11.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 5.11B | -74.84% |
| Dec 31, 2025 | 20.31B | 114.84% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Standard Chemical & Pharmaceutical | 9.85B |
| SCI Pharmtech | 6.07B |
| Orient Pharma | 5.48B |
| Formosa Laboratories | 5.38B |
| Yoda Pharmaceuticals | 4.84B |
| LIWANLI Innovation | 4.50B |
| Panion & Bf Biotech | 4.23B |
| Orient EuroPharma | 3.65B |